Bone Disorder Therapeutics: Novel Drug Candidates and Treatment Strategies
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 145
Special Issue Editor
Interests: osteoarthritis; drug delivery; gene delivery; biomaterials
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Bone disorders represent a significant global health burden, characterized by a diverse range of pathologies affecting bone structure and function. The development of innovative drug candidates and therapies to address these conditions remains a critical unmet medical need. This Special Issue aims to highlight cutting-edge research focused on the discovery, preclinical development, and clinical translation of promising therapeutic approaches for bone disorders.
We invite contributions that explore a wide spectrum of therapeutic modalities, including small molecules, biologics, gene therapies, and cell-based therapies. Potential topics of interest include, but are not limited to, the following:
- Novel drug targets and mechanisms of action;
- Formulation and delivery strategies;
- Preclinical efficacy and safety studies;
- Clinical trial design and outcomes;
- Biomarkers for disease progression and therapeutic response.
By fostering collaboration and knowledge exchange among researchers in academia, industry, and clinical settings, this Special Issue seeks to accelerate the development of effective treatments for patients with bone disorders.
Dr. Mahdi Rahimi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bone health
- osteoporosis
- arthritis
- osteoarthritis
- bone cancer
- regeneration
- repair
- metabolism
- gene therapy
- cell therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
